Epsilon Healthcare Limited

A$0.02As of Sun 8 Nov 2026, 12:00 UTC
ASX:EPNHealthcare
Country Australia
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE 50.27%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.59
PE TTM 148.1
TSR TTM —
Mkt cap A$7.782M
ROIC (8.45%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.019
(4.87%)
(42.42%)
Hold 7|11|11|1|3
4Q25
1Q26
2Q26
3Q26
Earnings per share$
—
—
—
—
18.70%
15.03%
4.37%
6.84%
Revenue$M
0.395
0.389
0.404
0.406
1.38%
0.91%
4.48%
2.48%
Peers (US$5.345M)
Cap (US$)
PE
5.703M
0.342x
4.921M
—
Capital
TTM
5Y
10Y
Leveragex
0.717
(0.100)
(0.081)
EBIT/Intx
2.287
0.173
0.187
Own earn%
(10.85)
(32.34)
(33.85)
Sh yield%
49.63
42.03
37.72
Owners
Insiders/Inst%
11.63
28.55
Short interest%
3.31
SBC / revenue%
4.17
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
23
Op margin range%
21–27
$1 testx
—
Incr. ROIC%
20